Lv61
1930 积分 2021-10-22 加入
Updated Survival Outcome of Regorafenib, Ipilimumab, and Nivolumab in Refractory Microsatellite Stable Non-Liver Metastatic Colorectal Cancer: A Phase I Nonrandomized Clinical Trial
22天前
已完结
Multiple initiatives to conquer KRAS G12C inhibitor resistance from the perspective of clinical therapy
1个月前
已完结
Current advances in targeted therapy for metastatic colorectal cancer – Clinical translation and future directions
1个月前
已完结
Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial
1个月前
已完结
Potent Covalent Irreversible Inhibitor of KRAS G12C IBI351 in Patients with Advanced Solid Tumors: First-In-Human Phase I Study
1个月前
已完结
Design, Structure Optimization, and Preclinical Characterization of JAB-21822, a Covalent Inhibitor of KRASG12C
2个月前
已完结
Glecirasib in KRAS(G12C)-mutated nonsmall-cell lung cancer: a phase 2b trial
2个月前
已完结
Tetrahydrofuran manufacture from 1, 4 butanediol: Feasibility of reactive chromatography
3个月前
已完结
Future changes in aridity in the Upper Indus Basin during the twenty-first century
3个月前
已关闭
Linkage of future regional climate extremes to global warming intensity
3个月前
已关闭
皖公网安备34019202002308
